chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had the first vaccine and then 2 weeks later she actually tested positive for COVID/ got COVID and her main symptom was a headache; had the first vaccine and then 2 weeks later she actually tested positive for COVID/ got COVID and her main symptom was a headache; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL9264), via an unspecified route of administration administered in the left arm on 04Mar2021 at a single dose for covid-19 immunisation. Medical history included cancer from 2014 (cancer survivor), had a mastectomy, 14 lymph nodes taken out the right side, hypothyroidism (thyroid condition) in 1990, osteopenia, and surgery in Dec2019 for a vaginal prolapse (they had gone in and done reconstruction). Concomitant medications included tamoxifen taken for cancer from an unspecified start date and ongoing; aspirin [acetylsalicylic acid] taken for an unspecified indication, start and stop date were not reported; calcium taken for osteopenia, start and stop date were not reported; vitamin c [ascorbic acid] taken for an unspecified indication, start and stop date were not reported; vitamin d taken for an unspecified indication, start and stop date were not reported; levothyroxine taken for hypothyroidism, start and stop date were not reported; levothyroxine sodium (SYNTHROID) taken for hypothyroidism, start and stop date were not reported. The patient had the first vaccine on 04Mar2021 and then 2 weeks later, on 18Mar2021, she actually tested positive for COVID. She stated she actually got COVID and her main symptom was a headache, like horrible, horrible headache. The doctors that she spoke with told her to wait 2 weeks ahead of her positive date to get the second vaccine. The outcome of the adverse events was unknown.
The patient complained of intense pain, became pale and appeared to have a near syncopal event.  She then complained of nausea, felt she was going to vomit but did not and was afraid she was going to die.  She was examined, all vitals were stable, and reassurance was provided.  The patient felt better and left the office with no further complaint after approximately 30 minutes
Booster 11/8/21 138pm felt heat on same side of injection traveling to the brain. Turned red on that side, feeling flushed,sob. 230pm feeling high,drugged,unable to concentrate, loss if reality, inability to drive normal,feel emotional,want to cry. 410-510 feeling high,loss of sense of reality,don't understand what's going on. Came home 410 crawled to bed and laid there for an hr eye wide open starring at the sealing,hallucinating space,stars,galaxies, pupils dilated.  11/9/21-11/10/21 upper abdominal pain, generalized pain internally and externally,joints,skin, temp 99.7. Dizzy, hives,itchy legs. Extreme pain at injection site ,no lymph nodes swelling. Sore throat. Feel body on fire, hard to concentrate.  Nose bleeds . 11/11/21 hard to concentrate,returned to work. Feel out of it,dizzy, look pale , shaky,weak,exhausted,swollen eyes,muffled ear sounds,sore throat  11/12/21 feeling a lil better still have nose bleeds,extreme fatigue, less shaky, groggy. 11/13-11/14 slowly returning to normal. 11/15/21 feeling OK. Still have hives anterior lower extremities.  11/16-11/18 very itchy skin: legs,arms,neck, upper back.  11/17 itchiness awoke me :extreme itchiness arms,hands,palms,fingers. Hives wrists,neck,lower legs upper back. 11/18-11/20 extreme generalized  raised hives that come and go on random places of the body.  11/19/21 via telodoc saw a physician and was prescribed epipen and prednisone.  11/20/21 have no improvement in symptoms. No change in diet,  clothing, perfumes,skin products etc...
Patient received vaccine on 2/12/2021 and 3/12/2021. He was admitted to the hospital on 6/23/2021 and passed away on 6/29/2021.
J96.00 ACUTE RESPIRATORY FAILURE 1/6/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 3/6/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/6/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 1/6/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 1/14/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED R09.02 HYPOXEMIA 2/1/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 1/6/2023 ACUTE RESPIRATORY FAILURE J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 3/6/2023 ACUTE RESPIRATORY FAILURE J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/6/2023 ACUTE RESPIRATORY FAILURE J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 1/6/2023 ACUTE RESPIRATORY FAILURE J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 1/14/2023 ACUTE RESPIRATORY FAILURE R09.02 HYPOXEMIA 2/1/2023 ACUTE RESPIRATORY FAILURE J96.00 ACUTE RESPIRATORY FAILURE 1/6/2023 COPD STAGE 3 SEVERE (FEV1 30-49%) J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 3/6/2023 COPD STAGE 3 SEVERE (FEV1 30-49%) J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/6/2023 COPD STAGE 3 SEVERE (FEV1 30-49%) J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 1/6/2023 COPD STAGE 3 SEVERE (FEV1 30-49%) J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 1/14/2023 COPD STAGE 3 SEVERE (FEV1 30-49%) R09.02 HYPOXEMIA 2/1/2023 COPD STAGE 3 SEVERE (FEV1 30-49%) J96.00 ACUTE RESPIRATORY FAILURE 1/6/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 3/6/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/6/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 1/6/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 1/14/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED R09.02 HYPOXEMIA 2/1/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 1/6/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 3/6/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/6/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 1/6/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 1/14/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED R09.02 HYPOXEMIA 2/1/2023 ADRENAL INSUFFICIENCY, UNSPECIFIED
Systemic: Rash (other than injection site)-Mild; symptoms lasted 1 day
Phone call from father @ 3:30 reporting his daughter just got dizzy, lowered to ground and fainted.  He was right there and able to catch her.  Following day father reports no further problems and fine today.
Developed (L) arm pain approximately 12 hours after vaccine administered. At 2 day exam - no inflammation heat or swelling. (+) muscle and tendon tenderness. Pain remains after 3 days.
Employee reports he developed tinnitus 8 hours after injection and has remained 4 days post injection with no history of tinnitus.
He did have positive PCR test result; He did have positive PCR test result; His symptoms were gastrointestinal issues including excessive diarrhea; His symptoms were gastrointestinal issues including excessive diarrhea; vomiting; passed away on Saturday, 09Jan; The initial case was missing the following minimum criteria: ICH-Reporter with No First-hand knowledge. Upon an updated that Pfizer colleague reported for a patients AE even the information did not come from the individual who experienced effects and has First-hand knowledge , this case now contains all required information to be considered valid.  This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 20-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death) with onset 09Jan2022, outcome "fatal", described as "passed away on Saturday, 09Jan"; DRUG INEFFECTIVE (death, medically significant), SARS-COV-2 TEST POSITIVE (death, medically significant), outcome "fatal" and all described as "He did have positive PCR test result"; GASTROINTESTINAL DISORDER (death), DIARRHOEA (death), outcome "fatal" and all described as "His symptoms were gastrointestinal issues including excessive diarrhea"; VOMITING (death), outcome "fatal". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. The patient date of death was 09Jan2022. Reported cause of death: "passed away on Saturday, 09Jan", "He did have positive PCR test result", "His symptoms were gastrointestinal issues including excessive diarrhea", "vomiting". It was not reported if an autopsy was performed. Additional information:  I am not aware which vaccine he received and have not reached out to ask. I completed my reporting training and will enter the information into the system.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: passed away on Saturday, 09Jan; He did have positive PCR test result; His symptoms were gastrointestinal issues including excessive diarrhea; vomiting; His symptoms were gastrointestinal issues including excessive diarrhea; He did have positive PCR t
Information has been received from a medical assistant, referring to a 4 month old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-SEP-2017, the patient was vaccinated with a dose of ROTATEQ lot # M032643 with expiration date on 04-MAR-2018, orally (strength and dose were not reported) for prophylaxis. On 18-SEP-2017, the patient proceeded to "sleep for 14-16 hours" (sleep disorder) and on 20-SEP-2017, she experienced vomiting. The outcome of the vomiting and the sleep disorder was reported as not recovered/not resolved and the causality between the vaccination with ROTATEQ and the aforementioned events was unknown.
All of the following adverse events started approximately 22 - 24 hours after vaccination:  Fever lasting  approximately 3 hours, temperature of 101.5 F/38.6 C, relieved with acetaminophen 1,000 mg PO x1 Chills lasting approximately 5 hours Muscle swelling lasting approximately 4 hours Muscle aches lasting >12 hours
This spontaneous report was received from a physician, via company representative, and refers to a patient of unknown age and gender. Pertinent medical history, concurrent conditions, drug reactions or allergies and concomitant therapies were not reported. On 10-JUN-2016, the patient was vaccinated with a dose of PNEUMOVAX 23 10 PK-0.5 ml SD-PFS LLokwTip, lot # L002310, expiration date 08-JUL-2016, (route and anatomical location of administration were unspecified) which was improperly stored in refrigerator to a temperature excursion of 0 Celsius degree for 168 hours and 1.1 Celsius degrees for 920 hours with lowest temperature recorded of 32 and 34 Fahrenheit degrees. No adverse effects were reported and no product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Diarrhea; Some pain in her chest and some breathing problems.; Some pain in her chest and some breathing problems.; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient). A 48-year-old female received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0198), via an unspecified route of administration, administered on 13Jul2021 (at the age of 48 years old) as a single dose for COVID-19 immunisation. Medical history included heart condition. The patient reported that she used to drink Aspirin of 81 mg just, as a preventive for any heart condition but it's been around 2 months, that she has stopped taking it. Concomitant medications were not reported. On an unspecified date the patient experienced Diarrhea and Some pain in her chest and some breathing problems. The patient stated that the reason that she was calling was, she had, her first shot of Pfizer BioNTech Covid-19 vaccine on 13Jul2021 and over the last couple of days, she has been having diarrhea and some pain in her chest and some breathing problem. When asked if she wants to report it, consumer stated, yes. The patient stated that she got the lab tests done before she got the first shot. The patient stated that before she gets the first shot, they made her a physique exam on 29Jun2021 and they made all the blood test cholesterol, blood glucose, they made a complete blood count. The patient reported that for diarrhea, it wasn't necessary because it was not that much, that she have diarrhea. For the respiration, for the breathing problem, she hasn't drink anything, that's why she was calling to know, what would be your recommendation, if she have to drink anything like Aspirin or what would you recommend before going to the hospital? Action(s) taken with drug was unknown. On 29Jun2021, the patient underwent lab test that included the blood test cholesterol, blood glucose and complete blood count, blood test with unknown results. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Administered expired doses of the Moderna COVID-19 vaccine; This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired doses of the Moderna COVID-19 vaccine) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A, 003B21A and 003B21A) for COVID-19 vaccination.     Previously administered products included for Drug use for unknown indication: Influenza (INFLUENZA, Series 1 and 10/18/2019). Past adverse reactions to the above products included No adverse event with Influenza. Concurrent medical conditions included Snoring, Long QT syndrome, Allergic rhinitis, Seasonal allergy, Prostate cancer, Colon cancer, Lung cancer, Hypertension, Hyperlipidemia, GERD and Coronary artery disease. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for Adverse event, AZELASTINE HCL for Allergy, LOSARTAN POTASSIUM, UBIDECARENONE (COQ10 [UBIDECARENONE]), VITAMIN C [ASCORBIC ACID], VITAMIN E NOS, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and CYANOCOBALAMIN (VITAMIN B-12) for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired doses of the Moderna COVID-19 vaccine). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administered expired doses of the Moderna COVID-19 vaccine) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Hepatic enzyme abnormal: abnormal (abnormal) abnormal. On an unknown date, Libido decreased: decreased (Low) Decreased.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Lab exam (ICD-V72.6) (ICD10-Z01.89) Sereen Shin Cancer (ICD-V76.43) (ICD10-Z12.83) Physical exam, routine (ICD-V70.0) (ICD10-Z00.00) Reported stated-Eye fillers Reporter stated, INFLUENZA, Series 1, 10/18/2019 INFLUENZA, Series 2, 9/25/2020 INFLUENZA, Series 3, 10/18/2021
pt recvd vax 17FEB93 & returned 25FEB93 p/recurrent sz activity was noticed for several days by mom;
30 minutes after injection I experienced dizziness/light headedness, mild facial numbness, numbness in lips and roof mouth. I returned to the vaccination distribution site - EMT's checked my O2, pulse and blood pressure which were all normal.  They check my blood sugar which was at 40.  I had eaten about 90 minutes before (egg, toast, coffee).  They administered glucose and rechecked 10 minutes later.  I was at 41.  I was oriented and by then the numbness and dizziness had subsided and has completely resolved. I experienced flu-like symptoms beginning in the evening of 1/22 and continuing consisting of tiredness, body aches, runny nose, sneezing, cough, stomach rumblings and diarrhea (mainly on 1/24).
WITHIN 10 MINUTES OF VACCINATION, PATIENT EXPERIENCED NAUSEA AND SWEATING. PT DENIED ANY OTHER SYMPTOMS. PT HAD NOT YET EATEN THAT DAY. RPH PROVIDED PT ORANGE JUICE, WATER AND PEANUT BUTTER CRACKERS.  PT DRANK ORANGE JUICE. PT DID NOT VOMIT. PT WAS PRESENT WITH PARENT AND PARENT STATED PATIENT WAS FEELING BETTER. PT AND PARENT LEFT AFTER OBSERVATION PERIOD.
Patient was given Tdap (Boostrix) and should have recieved Dtap (Infanrix).
Patient developed red macular rash in scalp and torso and ext. Also increased spitting up. No fever
Mother called this am 01/29/2002 stating that the child ran 101 deg. F. temp last night and was difficult to be awaken, right on the left thing. No fever at the time of call.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old male patient received BNT162b2 (BNT162B2), on 30Mar2022 as dose 4 (booster), single (Lot number: P24991) at the age of 55 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: CANNABIDIOL; FINASTERIDE; GLUCOSAMINE; TURMERIC CURCUMIN. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 14May2022, outcome "unknown", COVID-19 (medically significant) with onset 14May2022, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: negative; positive; Unknown result. Therapeutic measures were taken as a result of covid-19.  Clinical course: Approx. 4-5 days after completing the course of Paxlovid my symptoms returned: low grade fever, chills, fatigue, and congestion. I tested positive on rapid antigen tests for another 7 days before testing negative.
Fever 103 degrees F x 3 days, severe headache, chills symptoms started day after vaccine (<24 hours) sore throat. Neck pain persists after 8 days. No contacts became ill.
As with prior two doses of Moderna: instant mild headache, pressure in head, mild chest discomfort, fatigue/malaise, difficulty focusing
Complains of rash x 2 days. Started as a few spots on face and has been progressive. Now all over trunk, extremities, face. Minimally pruritic. New spots continue to emerge and old spots are filling with fluid/crusting. Has low grade fever first day of illness. He has been in daycare in the past month. Also received 12 month IZs (including varicella) 10 days ago. 10 days post vaccine administration, patient developed rash. Minimally pruritic. New spots continue to emerge and old spots are filling with fluid/crusting. Has low grade fever first day of illness.
Expired vaccine used; Temperature was out of range at 10 degree celcius for 1 hour and 20 minutes; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT STORAGE ERROR (Temperature was out of range at 10 degree celcius for 1 hour and 20 minutes) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus, Hypertension and Cholesterol. Concomitant products included METFORMIN, LOSARTAN and PRAVASTATIN for an unknown indication.    On 07-Oct-2021 at 9:21 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT STORAGE ERROR (Temperature was out of range at 10 degree celcius for 1 hour and 20 minutes). On 07-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT STORAGE ERROR (Temperature was out of range at 10 degree celcius for 1 hour and 20 minutes) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Vaccine was stored in refrigerator on 06 Oct 2021 at 3:30pm. The door of refrigerator was slightly open. Patient experience no side effects.  No treatment medication reported by reporter.
Vaccine administered 10/10/05 mom states redness appeared next day 10/11/05.  On 10/13/05 patient started guarding leg.  Mom states she tried or is doing no treatment for any symptoms.  Small vesicle appeared 10/19/05 (maybe from mosquito bites mom states) bilateral leg appears to have bites.
Patient reported red, hot, itchy skin at reaction site. She sought care from her PCP.
I started receiving sharp burning pain in my left arm from my shoulder to my finger tips with 48 hours of receiving my 1st covid shot. I am still having the same pain 2 months later hower it is now traveling to my neck and chest.
Moderna COVID-19 Vaccine EUA Within a minute of receiving the vaccine, I walked about 40-50 feet and experienced extreme dizziness and shortness of breath, and could not stand straight. I was able to stop my own fall due to a wall being next to me, and I stooped down close to the floor so as to prevent a fall. I then was able to walk about 20 feet to an office where I could sit and the dizziness continued. I noticed I was shaking and heartrate was elevated (that could have been the anxiety caused by the dizziness and being unable to walk straight). I sat for a total of 30 minutes before I walked to my office, which is a couple minute walk. I continued to have dizzy spells (not as severe) while sitting in my office for a few more hours. Also, I'm having a hard time focusing, feel dazed.
My COVID-19 Infection symptoms started on  11/17/2022 at around 8:00AM in the morning. I had slight fever, cough, and  tiredness. I did a home COVID-19 test which was positive. I called my doctor right away after testing positive. He prescribed  Legevrio  8 pills  per day, pack of 40 pills in total.
elevated liver enzymes; This spontaneous case was reported by a consumer and describes the occurrence of HEPATIC ENZYME INCREASED (elevated liver enzymes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEPATIC ENZYME INCREASED (elevated liver enzymes). At the time of the report, HEPATIC ENZYME INCREASED (elevated liver enzymes) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Apr-2021, Blood test: unknown (abnormal) Hepatic enzymes elevated. On 26-Apr-2021, Ultrasound scan: unknown (Inconclusive) Unknown.         No concomitant medications reported by investigator   This case was linked to MOD-2021-042851 (Patient Link).
noticed inc hair loss/breakage since JAN94 occurring 1 wk p/last vax; shedding from roots p/2nd vax; perms hair every 3 months: most recent SEP93 & DEC93;